Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives

[1]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[2]  P Taylor,et al.  Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. , 1975, Biochemistry.

[3]  A. Goldberg,et al.  Biology of cholinergic function , 1976 .

[4]  D. Quinn,et al.  Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states , 1987 .

[5]  E. J. Glamkowski,et al.  Tetracyclic benzodiazepines. 4. Synthesis of the novel benzo[c]pyrrolo[1,2,3-ef][1,5]benzodiazepine ring system, and derivatives with potential antipsychotic activity , 1987 .

[6]  M. Pomponi,et al.  New analogs of physostigmine: alternative drugs for Alzheimer's disease? , 1988, Life sciences.

[7]  E. Giacobini,et al.  Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects , 1988 .

[8]  S. Gauthier,et al.  Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. , 1990, The New England journal of medicine.

[9]  D. Pessayre,et al.  Acute hepatitis after tetrahydroaminoacridine administration for Alzheimer's disease. , 1990, Journal of clinical gastroenterology.

[10]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[11]  E. Giacobini,et al.  Alzheimer disease : therapeutic strategies , 1994 .